Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Intrathecal Injection of Autologous Mesenchymal Stem-Cell-Derived Extracellular Vesicles in Spinal Cord Injury: A Feasibility Study in Pigs

Intrathecal Injection of Autologous Mesenchymal Stem-Cell-Derived Extracellular Vesicles in Spinal Cord Injury: A Feasibility Study in Pigs

Int. J. Mol. Sci., 2023 · DOI: 10.3390/ijms24098240 · Published: May 4, 2023

Spinal Cord InjuryRegenerative MedicineGenetics

Simple Explanation

This study investigates a new way to help the spinal cord heal after an injury using tiny particles called extracellular vesicles (EVs) that come from stem cells. The EVs were injected directly into the spinal fluid of pigs with spinal cord injuries to see if it could help them regain movement. The research also looked at the best way to prepare these EVs from stem cells to ensure they are effective for treatment.

Study Duration
12 weeks
Participants
5 pigs per group (SCI and SCI + EVs)
Evidence Level
Not specified

Key Findings

  • 1
    The study found that a specific method of preparing EVs, involving vortex mixing and filtration, resulted in more uniform and smaller vesicles.
  • 2
    Pigs that received the EVs showed some improvement in their ability to move, suggesting the treatment might help restore locomotor activity.
  • 3
    The EVs seemed to help by stimulating the remyelination of nerve fibers and improving blood flow to the injured spinal cord tissue.

Research Summary

This study evaluated the feasibility of using autologous mesenchymal stem cell-derived extracellular vesicles (EVs) injected intrathecally to treat spinal cord injury (SCI) in pigs. The researchers optimized a method for obtaining EVs and assessed the therapeutic potential of repeated EV injections in the subacute phase of SCI. The results indicated partial restoration of locomotor activity, stimulated remyelination of axons, and improved reperfusion of nervous tissue, suggesting a potential therapeutic effect of EVs.

Practical Implications

Clinical Translation

The use of AT-MSC-derived EVs could potentially become a convenient and readily available source for use in clinical practice.

Therapeutic Strategy

Intrathecal injection of AT-MSC-derived EVs in the subacute period of SCI could help improve locomotor activity by stimulating the remyelination of axons and timely reperfusion of nervous tissue.

Further Research

Future studies should focus on revealing in more detail the molecular mechanisms of angiogenesis, myelination, immunomodulation, and other processes in the treatment of AT-MSC-derived EVs.

Study Limitations

  • 1
    [object Object]
  • 2
    [object Object]
  • 3
    [object Object]

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury